ENSURE PLUS ADVANCE JAHODOVÁ PŘÍCHUŤ

Základní informace

  • Název přípravku:
  • ENSURE PLUS ADVANCE JAHODOVÁ PŘÍCHUŤ Perorální roztok
  • Léková forma:
  • Perorální roztok
  • Podání:
  • Perorální podání
  • Jednotky v balení:
  • 4X220ML Lahev
  • Použij pro:
  • Lidé
  • Léčitelství typu:
  • alopatický drog

Dokumenty

Lokalizace

  • K dispozici v:
  • ENSURE PLUS ADVANCE JAHODOVÁ PŘÍCHUŤ Perorální roztok
    Česká republika
  • Jazyk:
  • čeština

Terapeutická informace

  • Terapeutické oblasti:
  • POTRAVINY PRO ZVLÁŠTNÍ LÉKAŘSKÉ ÚČELY (PZLÚ)
  • Přehled produktů:
  • ENSURE PLUS ADVANCE JAHODOVÁ PŘÍCHUŤ

Další informace

Stav

  • Zdroj:
  • SUKL - Státní ústav pro kontrolu léčiv
  • Poslední aktualizace:
  • 22-06-2017

Příbalovou informaci pro pacienta

165-041-000

S757

Abbott2016

ENSURE PLUS ADVANCE

Jahodová příchuť

Potravina pro zvláštní lékařské účely

1,5 kcal/ml

1,5g CaHMB

330kcal

20g bílkovin

13mcg vitamínu D

Ve 220ml

Kompletní vyvážená výživa, speciálně připravená tak, aby splňovala požadavky na výživu

starších dospělých jedinců. Dietní potravina pro zvláštní lékařské účely.

e4x220ml

Určeno k dietnímu postupu u dospělých s podvýživou a/nebo při ztrátou svalové hmoty, síly

a funkčnosti.

Ensure Plus Advance je vysoce kalorická, kompletní a vyvážená perorální výživa bohatá na

bílkoviny a vitamín D s obsahem FOS* a CaHMB**. Návod k použití: Připraveno k použití.

Před otevřením dobře protřepejte. Po otevření výrobek uzavřete, uchovávejte v chladničce a

spotřebujte do 24hodin. Neotevřenou výživu uchovávejte při pokojové teplotě.

Důležité upozornění: Ensure Plus Advance je doplňkový zdroj výživy. Používejte na základě

doporučení lékaře nebo osoby kvalifikované v oblasti výživy lidí, farmacie nebo péče o matku

a dítě. Není určeno pro děti, pokud to nedoporučí lékař nebo osoba kvalifikovaná v oblasti

výživy. Neužívat při galaktosémii. Není určeno k parenterálnímu použití. Bez lepku.

Doporučené dávkování: 2 balení denně.

Složení: voda, hydrolyzovaný kukuřičný škrob, mléčné bílkoviny, sacharóza, rostlinný olej

(řepkový,

kukuřičný),

izolovaná

sójová

bílkovina,

FOS*,

minerály

(citronan

draselný,

fosforečnan vápenatý, citronan sodný, uhličitan hořečnatý, chlorid draselný, síran železnatý,

síran zinečnatý, síran manganatý, síran měďnatý, molybdenan sodný, jodid draselný, chlorid

chromitý, selenan sodný), CaHMB**, aroma, emulgátor: sójový lecitin, stabilizátory (E460,

E466,

E418),

cholin-chlorid,

regulátor

kyselosti:

E525,

vitamíny

nikotinamid,

pantothenan vápenatý, beta-karoten, B

, vit. A palmitát, kyselina listová, K

biotin, B

), L-karnitin, barvivo: E120.

*Fruktooligosacharidy.

**Monohydrát beta-hydroxy-beta-metylbutyrátu vápenatého.

Minimální trvanlivost do konce:

Balené v ochranné atmosféře.

Vyrobeno v EU.

CZ: Abbott Laboratories, s.r.o., Hadovka Office Park, Evropská 2591/33d, 160 00 Praha 6,

Česká republika

165-041-000

S757

Abbott2016

Informace o výživové hodnotě

Jednotka

ve 100 ml

ve 220 ml

Energetická hodnota

kcal

631/150

1388/330

Tuky

4,80

10,56

Nasycené mastné kyseliny

0,45

0,99

Sacharidy

16,80

36,96

Cukry

15,0

Vláknina (FOS*)

0,75

1,65

Bílkoviny

9,10

20,02

Sůl

0,38

0,83

0,55

1,21

Karnitin

Cholin

Vitamín A (palmitát)

mcg RE

Vitamín A (beta-karoten)

mcg RE

Vitamín D

12,5

Vitamín E

mg α-TE

Vitamín K

Vitamín C

Kyselina listová

Vitamín B

0,26

0,57

Vitamín B

0,32

0,70

Vitamín B

0,30

0,66

Vitamín B

0,65

1,43

Niacin

mg NE

Kyselina pantothenová

Biotin

13,2

Sodík

Draslík

Chlór

Vápník

Fosfor

Hořčík

Železo

Zinek

1,75

3,85

Mangan

0,45

0,99

Měď

Jód

Selen

19,8

Chrom

18,7

Molybden

Osmolarita

557 mOsm/l

EAN 8710428008046

165-041-000

S757

Abbott2016

ENSURE PLUS ADVANCE

Jahodová příchuť

1 lahvička 220ml

samostatně neprodejné

1,5 kcal/ml

1,5g CaHMB

330kcal

20g bílkovin

13mcg vitamínu D

Ve 220ml

Kompletní vyvážená strava, speciálně připravená tak, aby splňovala požadavky na výživu

starších dospělých jedinců.

Dietní potravina pro zvláštní lékařské účely. Určeno k dietnímu postupu u dospělých s

podvýživou a/nebo při ztrátou svalové hmoty, síly a funkčnosti.

Ensure Plus Advance je vysoce kalorická, kompletní a vyvážená perorální výživa bohatá na

bílkoviny a vitamín D s obsahem FOS* a CaHMB**.

Další informace naleznete na vnějším obalu. Samostatně neprodejné. Obsahuje mléko a sóju.

EAN 8710428008039

12-7-2018

Statement by FDA Commissioner Scott Gottlieb, M.D., on formation of a new drug shortages task force and FDA’s efforts to advance long-term solutions to prevent shortages

Statement by FDA Commissioner Scott Gottlieb, M.D., on formation of a new drug shortages task force and FDA’s efforts to advance long-term solutions to prevent shortages

FDA Commissioner Scott Gottlieb, M.D., on new drug shortages task force and work towards long-term solutions to prevent shortages

FDA - U.S. Food and Drug Administration

12-7-2018

FDA expands its support for states to advance implementation of produce safety activities

FDA expands its support for states to advance implementation of produce safety activities

FDA expands its support for states to advance implementation of produce safety activities

FDA - U.S. Food and Drug Administration

11-7-2018

Statement from FDA Commissioner Scott Gottlieb, M.D. on agency’s efforts to advance development of gene therapies

Statement from FDA Commissioner Scott Gottlieb, M.D. on agency’s efforts to advance development of gene therapies

Statement from FDA Commissioner Scott Gottlieb, M.D. on agency’s efforts to advance development of gene therapies, including three disease specific draft guidances

FDA - U.S. Food and Drug Administration

28-6-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on developments in the romaine outbreak investigation, recent outbreaks and the use of modern tools to advance food safety

Statement from FDA Commissioner Scott Gottlieb, M.D., on developments in the romaine outbreak investigation, recent outbreaks and the use of modern tools to advance food safety

Being able to identify outbreaks is key to being able to take quick action to prevent additional illnesses and find the source of the contamination. In recent years, the FDA and the Centers for Disease Control and Prevention (CDC) have advanced new tools that make it easier and faster to identify outbreaks of human illness and to link them back to the food source that is the culprit responsible for the illnesses. But our improved ability to spot outbreaks has also caused some to question whether we are e...

FDA - U.S. Food and Drug Administration

26-6-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s new steps to advance health through improvements in nutrition under the agency’s Nutrition Innovation Strategy

Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s new steps to advance health through improvements in nutrition under the agency’s Nutrition Innovation Strategy

Announcement of public meeting to solicit input on plans to modernize food standards and labeling

FDA - U.S. Food and Drug Administration

12-6-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on new agency efforts to advance the patient voice in medical product development and FDA regulatory decision-making

Statement from FDA Commissioner Scott Gottlieb, M.D., on new agency efforts to advance the patient voice in medical product development and FDA regulatory decision-making

FDA issues draft guidance on collecting patient experiences to inform the development and evaluation of medical products

FDA - U.S. Food and Drug Administration

12-6-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on new efforts to advance medical product communications to support drug competition and value-based health care

Statement from FDA Commissioner Scott Gottlieb, M.D., on new efforts to advance medical product communications to support drug competition and value-based health care

Statement from FDA Commissioner Scott Gottlieb, M.D., on new efforts to advance medical product communications to support drug competition and value-based health care

FDA - U.S. Food and Drug Administration

5-6-2018

FDA and USDA announce key step to advance collaborative efforts to streamline produce safety requirements for farmers

FDA and USDA announce key step to advance collaborative efforts to streamline produce safety requirements for farmers

FDA and USDA announce key step to advance collaborative efforts to streamline produce safety requirements for farmers by aligning USDA program with FDA’s Produce Safety Rule requirements.

FDA - U.S. Food and Drug Administration

22-5-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on new FDA actions to keep consumers safe from the harmful effects of sun exposure, and ensure the long-term safety and benefits of sunscreens

Statement from FDA Commissioner Scott Gottlieb, M.D., on new FDA actions to keep consumers safe from the harmful effects of sun exposure, and ensure the long-term safety and benefits of sunscreens

The FDA is announcing three new efforts as part of a comprehensive set of actions to advance the FDA’s framework for sun protection products ahead of this coming summer

FDA - U.S. Food and Drug Administration

17-5-2018

Intent to submit a marketing authorisation application for a veterinary medicinal product using the decentralised procedure with France as a Reference Member State (RMS).

Intent to submit a marketing authorisation application for a veterinary medicinal product using the decentralised procedure with France as a Reference Member State (RMS).

An applicant intending to submit a marketing authorisation application for a veterinary medicinal product using the decentralised procedure with France acting as RMS has to inform the Anses-ANMV at least 2 months in advance.

France - Agence Nationale du Médicament Vétérinaire

15-5-2018

Nonprescription Drugs Advisory Committee

Nonprescription Drugs Advisory Committee

he Nonprescription Drugs Advisory Committee advises the Commissioner or designee in discharging responsibilities as they relate to helping to ensure safe and effective drugs for human use and, as required, any other product for which the Food and Drug Administration has regulatory responsibility.

FDA - U.S. Food and Drug Administration

2-6-2017

Additional Risk Minimisation Measures (aRMM)

Additional Risk Minimisation Measures (aRMM)

From 1 June 2017 IMA will take seven days to ensure that all relevant documents are enclosed in an application for aRMM evaluation. This is done to facilitate IMAs review of the material.

IMA - Icelandic Medicines Agency

18-12-2006

Reassessment of reimbursement status

Reassessment of reimbursement status

This summer, the Danish Medicines Agency will begin the periodic reassessment of reimbursement status of medicinal products. Over a 5-year period, the reimbursement status of all medicinal products will be reassessed to ensure that the medicinal products having been granted general reimbursement still meet the required criteria and that medicinal products which have not been granted general reimbursement do not meet the criteria.

Danish Medicines Agency

10-7-2018

News and press releases:  EMA identifies gaps in industry preparedness for Brexit

News and press releases: EMA identifies gaps in industry preparedness for Brexit

Survey indicates that some companies need to step up efforts to ensure medicine supply in the EU

Europe - EMA - European Medicines Agency

5-6-2018

Advance notice - update to an eCTD file download for version 3.1

Advance notice - update to an eCTD file download for version 3.1

The TGA intends to make a small amendment to the eCTD validation criteria

Therapeutic Goods Administration - Australia

29-5-2018

Ensure that you have optimised your Class I medical device ARTG entries

Ensure that you have optimised your Class I medical device ARTG entries

Information sheet to assist sponsors to optimise their Class I ARTG

Therapeutic Goods Administration - Australia

22-5-2018

Statement from @SGottliebFDA on new FDA actions to keep consumers safe from the harmful effects of sun exposure, and ensure the long-term safety and benefits of sunscreens:  http://go.usa.gov/xQmjP 

Statement from @SGottliebFDA on new FDA actions to keep consumers safe from the harmful effects of sun exposure, and ensure the long-term safety and benefits of sunscreens: http://go.usa.gov/xQmjP 

Statement from @SGottliebFDA on new FDA actions to keep consumers safe from the harmful effects of sun exposure, and ensure the long-term safety and benefits of sunscreens: http://go.usa.gov/xQmjP 

FDA - U.S. Food and Drug Administration